Instructor of Medicine, University of Chicago Medicine

Hematology

Daniel Catenacci practices Hematology. He researched medicine at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Daniel V. Catenacci, MD is a published doctor. He published 14 publications, including: 'New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing.' Dr. Daniel V. Catenacci accepts all Medicare patients.

Publications

---

• Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies.
• New Routes to Targeted Therapy of Intrahepatic CholangioCarcinomas Revealed by Next-Generation Sequencing.
• Perioperative therapy for locally advanced gastroesophageal Cancer: current controversies and consensus of care.
• Gastroesophageal Cancer: focus on epidemiology, classification, and staging.
• Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric Cancer.
• Differential expression of RON in small and non-small cell lung Cancers.
• Toward personalized treatment of advanced biliary tract Cancers.
• Durable complete response of metastatic gastric Cancer with anti-Met therapy followed by resistance at recurrence.
• RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenoCarcinoma.
• Molecular profiling of Cancer--the future of personalized Cancer medicine: a primer on Cancer biology and the tools necessary to bring molecular testing to the clinic.
• Personalized colon Cancer care in 2010.
• A survey of the population genetic variation in the human kinome.
• Myelodysplasic syndromes: a comprehensive review.

Schools

---

• Wayne State University

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• Bile Duct Cancer
• View All

Doctors Specialties

---

• Gastrointestinal Oncology
• Medical Oncology
• Oncology
• Hematology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• University of Chicago
• UCLA Medical Center
• Wayne State University School of Medicine

Hospital

---

• University of Chicago Medical Center

Drug Facts

---

NPI NUMBER		1467609537
NPPES Provider LastName		CATENACCI
NPPES Provider FirstName		DANIEL
NPPES Provider ZIPCode		606371447
NPPES Provider State		IL
Specialty Description		Hematology/Oncology
Total Claim Count		147.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1467609537
Last Name Of The Provider	CATENACCI
First Name Of The Provider	DANIEL
View All

Similar Doctors

---

	Dr. Laura Raftery, MD This Doctor is OpenDoctor Recommended.
	Dr. Al B. Benson III, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Andrzej J. Jakubowiak, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David J. Peace, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mary J. Fidler, MD This Doctor is OpenDoctor Recommended.
	Dr. Leonardo N. Faoro, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Juan R. Chediak, MD This Doctor is OpenDoctor Recommended.
	Dr. Sairah Ahmed, MD This Doctor is OpenDoctor Recommended.
	Dr. Shaina A. Rozell, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog